GPAM Antibody

Code CSB-PA875724LA01HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human endometrial cancer using CSB-PA875724LA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human adrenal gland tissue using CSB-PA875724LA01HU at dilution of 1:100

  • Western Blot
    Positive WB detected in: Rat heart tissue, Mouse heart tissue
    All lanes: GPAM antibody at 3.4μg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 94 kDa
    Observed band size: 94 kDa

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) GPAM Polyclonal antibody
Uniprot No.
Target Names
GPAM
Alternative Names
Glycerol 3 phosphate acyltransferase 1 mitochondrial antibody; Glycerol 3 phosphate acyltransferase mitochondrial antibody; Glycerol-3-phosphate acyltransferase 1 antibody; Gpam antibody; GPAT antibody; GPAT-1 antibody; GPAT1 antibody; GPAT1_HUMAN antibody; KIAA1560 antibody; MGC26846 antibody; mitochondrial antibody; RP11-426E5.2 antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse, Rat
Immunogen
Recombinant Human Glycerol-3-phosphate acyltransferase 1, mitochondrial protein (281-459AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The GPAM Antibody (Product code: CSB-PA875724LA01HU) is Non-conjugated. For GPAM Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA875724LB01HU GPAM Antibody, HRP conjugated ELISA
FITC CSB-PA875724LC01HU GPAM Antibody, FITC conjugated
Biotin CSB-PA875724LD01HU GPAM Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC
Recommended Dilution
Application Recommended Dilution
WB 1:200-1:3000
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Esterifies acyl-group from acyl-ACP to the sn-1 position of glycerol-3-phosphate, an essential step in glycerolipids biosynthesis such as triglycerides, phosphatidic acids and lysophosphatidic acids.
Gene References into Functions
  1. High GPAM expression is associated with Ovarian Carcinoma. PMID: 28652252
  2. two transcriptional initiation sites and two promoters (promoter I and II) required for expression of the human GPAT1 (hGPAT1) gene were identified. PMID: 22634312
  3. Results suggest that GPAM is expressed in human breast cancer with associated changes in the cellular metabolism, in particular an increased synthesis of phospholipids, the major structural component of cellular membranes. PMID: 22070544
Subcellular Location
Mitochondrion outer membrane; Multi-pass membrane protein.
Protein Families
GPAT/DAPAT family
Database Links

HGNC: 24865

OMIM: 602395

KEGG: hsa:57678

STRING: 9606.ENSP00000265276

UniGene: Hs.42586

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*